These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37046405)

  • 1. Multidisciplinary management in the treatment of intrahepatic cholangiocarcinoma.
    Ruff SM; Diaz DA; Pitter KL; Hartwell BC; Pawlik TM
    CA Cancer J Clin; 2023; 73(4):346-352. PubMed ID: 37046405
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Advances in the Multidisciplinary Management of Intrahepatic Cholangiocarcinoma.
    Cloyd JM; Ejaz A; Pawlik TM
    Ann Surg Oncol; 2020 Aug; 27(8):2866-2867. PubMed ID: 32444910
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholangiocarcinoma: preventing invasion as anti-cancer strategy.
    Gores GJ
    J Hepatol; 2003 May; 38(5):671-3. PubMed ID: 12713880
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholangiocarcinoma: current concepts and insights.
    Gores GJ
    Hepatology; 2003 May; 37(5):961-9. PubMed ID: 12717374
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical pathology of cholangiocarcinoma (intrahepatic bile duct cancer)].
    Yamamoto M
    Nihon Geka Hokan; 1995 Nov; 64(6):129-30. PubMed ID: 8913088
    [No Abstract]   [Full Text] [Related]  

  • 6. More than shots in the dark: improving patient stratification to move closer to personalised therapies in intrahepatic cholangiocarcinoma.
    Arechederra M; Casadei Gardini A; Raggi C
    Gut; 2024 Feb; 73(3):389-390. PubMed ID: 37890989
    [No Abstract]   [Full Text] [Related]  

  • 7. Cholangiocarcinoma.
    Krasinskas AM
    Surg Pathol Clin; 2018 Jun; 11(2):403-429. PubMed ID: 29751883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma.
    Bowlus CL; Arrivé L; Bergquist A; Deneau M; Forman L; Ilyas SI; Lunsford KE; Martinez M; Sapisochin G; Shroff R; Tabibian JH; Assis DN
    Hepatology; 2023 Feb; 77(2):659-702. PubMed ID: 36083140
    [No Abstract]   [Full Text] [Related]  

  • 9. Distal cholangiocarcinoma.
    Lad N; Kooby DA
    Surg Oncol Clin N Am; 2014 Apr; 23(2):265-87. PubMed ID: 24560110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidisciplinary treatment for hilar and intrahepatic cholangiocarcinoma: A review of the general principles.
    Sapisochin G; Ivanics T; Subramanian V; Doyle M; Heimbach JK; Hong JC
    Int J Surg; 2020 Oct; 82S():77-81. PubMed ID: 32380231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The multidisciplinary management of cholangiocarcinoma.
    Ohaegbulam KC; Koethe Y; Fung A; Mayo SC; Grossberg AJ; Chen EY; Sharzehi K; Kardosh A; Farsad K; Rocha FG; Thomas CR; Nabavizadeh N
    Cancer; 2023 Jan; 129(2):184-214. PubMed ID: 36382577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholangiocarcinoma: new insights into disease pathogenesis and biology.
    Braconi C; Patel T
    Infect Dis Clin North Am; 2010 Dec; 24(4):871-84, vii. PubMed ID: 20937455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the management of cholangiocarcinoma.
    Skipworth JR; Keane MG; Pereira SP
    Dig Dis; 2014; 32(5):570-8. PubMed ID: 25034290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and molecular abnormalities in cholangiocarcinogenesis.
    Hassid VJ; Orlando FA; Awad ZT; Tan D; Khoury T; Ahmed BH; Alrawi SJ
    Anticancer Res; 2009 Apr; 29(4):1151-6. PubMed ID: 19414358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic management of hilar cholangiocarcinoma--one stent or two?
    Hatfield AR
    Bildgebung; 1995 Oct; 62 Suppl 2():53-4. PubMed ID: 8589585
    [No Abstract]   [Full Text] [Related]  

  • 16. Intrahepatic Carcinosarcoma With Cholangiocarcinoma Elements and Prominent Bile Duct Spread.
    Usui G; Hashimoto H; Kusakabe M; Shirota G; Sugiura Y; Fujita Y; Satou S; Harihara Y; Horiuchi H; Morikawa T
    Int J Surg Pathol; 2019 Dec; 27(8):900-906. PubMed ID: 31203684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel multimodality treatment sequencing for extrahepatic (mid and distal) cholangiocarcinoma.
    Turaga KK; Tsai S; Wiebe LA; Evans DB; Gamblin TC
    Ann Surg Oncol; 2013 Apr; 20(4):1230-9. PubMed ID: 23064778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation-induced liver disease secondary to adjuvant therapy for extra-hepatic cholangiocarcinoma.
    Peixoto A; Pereira P; Bessa de Melo R; Macedo G
    Dig Liver Dis; 2017 Feb; 49(2):227. PubMed ID: 28089215
    [No Abstract]   [Full Text] [Related]  

  • 19. Is it Possible to Increase Survival of Patients with Intrahepatic Cholangiocarcinoma? A Case Report.
    Oguz S; Kucukaslan H; Topaloglu S; Ones T; Baltacioglu F; Cobanoglu U; Calik A
    J Gastrointest Cancer; 2021 Mar; 52(1):342-346. PubMed ID: 32617830
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatobiliary cancers, version 2.2014.
    Benson AB; D'Angelica MI; Abrams TA; Are C; Bloomston PM; Chang DT; Clary BM; Covey AM; Ensminger WD; Iyer R; Kelley RK; Linehan D; Malafa MP; Meranze SG; Park JO; Pawlik T; Posey JA; Scaife C; Schefter T; Sigurdson ER; Tian GG; Vauthey JN; Venook AP; Yen Y; Zhu AX; Hoffmann KG; McMillian NR; Sundar H
    J Natl Compr Canc Netw; 2014 Aug; 12(8):1152-82. PubMed ID: 25099447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.